Differentiation in neoplastic disease of the lymphoreticular system is inseparable from the problems of tumour nomenclature, and there can be few other aspects of oncology which have been so confused by 'a chaos of names' (Willis, 1967) and by such a multiplicity of suggested classifications. This is due in part to the fact that the lymphoreticular system is diffused widely through the body, and that many of its cells normally circulate in the peripheral blood and are involved in immune responses of various kinds including the synthesis of immunoglobulins. Thus, depending on which aspect of the neoplastic process is predominant, the disease may be named on the basis of the histological appearances of a tumour mass ('malignant lymphoma', 'lymphosarcoma' etc), according to cytological patterns in the peripheral blood and bone marrow ('leukaemia') or in accordance with changes in the plasma proteins (eg, 'macroglobulinaemia', 'heavy chain disease', 'alpha-chain disease'). In fact, in a given case, the histological findings, the blood picture, and the biochemical alterations are best regarded as different facets of a single underlying disease process. It is clear that close cooperation between histopathologists, haematologists, chemical pathologists, immunologists, and cytologists is vital in the proper assessment of an individual case, and in the establishment of a generally acceptable classification of lymphoreticular neoplasms. Furthermore, in any such (new) classification, consideration must be given to more recent advances in our knowledge of cell function and kinetics, such as the functional dichotomy of lymphocytes into tiymic-dependent (T) and bursa-dependent (B) populations. RobbSmith (1938) formulated a detailed classification of the 'reticuloses' and 'reticulosarcomas' based on the differentiating cell type, and (in the case of the reticuloses) on which part of the lymph node was primarily involved in the cellular proliferation-the sinuses, the follicles, or the medulla. Unfortunately, the term 'reticulosis' has proved unsatisfactory, since it was used to cover benign reactive processes, 103
conditions which are now considered to be neoplastic (such as follicular lymphoma) and lipid storage diseases. Gall and Mallory (1942) (Gall and Rappaport, 1958) . Rappaport (1964 Rappaport ( , 1966 has extended the scope of this scheme to produce a comprehensive classification, including neoplastic proliferations of the myeloid, plasmacytic, and erythrocytic series. In any classification, allowance must be made for the possible introduction of further types, or subtypes, as newly recognized clinicopathological entities become documented. For example, Burkitt's lymphoma is now regarded as a neoplasm distinct from other types of poorly differentiated lymphoblastic lymphoma (Burkitt and Wright, 1970) and differing in its cytology, morbid anatomy, clinical manifestations, and frequency of leukaemic transformation from the type of childhood lymphosarcoma more commonly seen in (for example) the United Kingdom (Wright, 1966; Wright, 1967) . A further instance of a recently recognized subtype is the 'nodular sclerotic lymphosarcoma' described by Bennett and Millett (1969) and Millett, Bennett, Jelliffe, and Farrer-Brown (1969) . RETICULUM CELL SARCOMA This term has been used loosely to designate any malignant lymphoid tumour featuring large cells which cannot be readily assigned to a particular differentiated series (lymphocytic, myelocytic, plasmacytic, etc) . Indeed the nature and function of normal 'reticulum cells' have been long in doubt and there has been much confusion of terminology. Gall and Mallory (1942) pointed out that the type cell of 'reticulum cell sarcomas' has been interpreted variously as (1) an immature cell of the lymphocytic series, (2) a pluripotential cell, and (3) a relatively well differentiated cell of the monocytic or clasmatocytic series. Marshall (1956) believes that 'primitive reticular cells' can become 'activated' and are capable of differentiating into fibroblasts, lymphocytes, plasmacytes, all types of blood cells, and macrophages. However, in a discussion of reticulosarcomas, Marshall considers some of these tumours to consist of cells resembling the primitive reticular cells, and others to be anaplastic growths of indeterminate cell type. Rappaport (1966) follows Gall and Mallory (1942) in subdividing 'reticulum cell sarcomas' into undiffererntiated and histiocytic forms. Peckham and Cooper (1969) consider 'reticulum cell' to be synonymous with 'histiocyte'. Hartsock (1968) in a discussion of post-vaccinal lymphadenitis, uses the term 'reticular lymphoblast' for large cells with pyroninophilic cytoplasm and prominent nucleoli and which are probably transformed lymphocytes either of the B or T type. Okano, Azar, and Osserman (1966) speak of a 'plasmacytic reticulum cell sarcoma' in their report of a tumour, judged to be a reticulum cell sarcoma on the basis of its cytomorphology (in haematoxylin and eosin preparations) and reticulin formation, but featuring cytoplasmic pyroninophilia, abundant rough-surfaced endocytoplasmic reticulum, and the production of a myeloma-type protein demonstrated by electrophoretic analysis of the patient's serum.
Several workers now use the term 'reticulum cell sarcoma' as synonymous with malignant lymphoma of histiocytic type (Mathe, Gerard-Marchant, Texier, Schlumberger, Berumen, and Paintrand, 1970; Rosas-Uribe and Rappaport, 1972) . Some of the histiocytic neoplasms feature abundant reticulin and collagen formation; such tumours have been called 'sclerosing reticulum cell sarcomas', and the production of collagen is in accord with the demonstration by Ozzello, Stout, and Murray (1963) Baehr and Rosenthal (1927) and 'lymphoid follicular reticulosis' by Robb-Smith (1938) , it was considered to be a distinct tumour type, although variation in the cellular composition of the neoplastic follicles was recognized (Gall, Morrison, and Scott, 1941) Hodgkin's disease and acute lymphoblastic leukaemia (Lacher and Sussman, 1963 ), Hodgkin's disease and acute lymphosarcoma cell leukaemia (Bums, Stjernholm, and Kellermeyer, 1971) , Hodgkin's disease and DiGuglielmo's leukaemia (Durant and Tassoni, 1967 ), Hodgkin's disease and chronic lymphocytic leukaemia (Oberfield, 1966; Tornyos, Macossay, and Gyorkey, 1967) , plasma cell myeloma and acute monocytic leukaemia (Osserman and Lawler, 1966) , and well differentiated lymphocytic lymphoma and acute myeloid leukaemia (Weiss, Brunning, and Kennedy, 1972) .
The appearance of highly aggressive lymphoreticular tumours in patients with chronic lymphocytic leukaemia is an uncommon but well documented phenomenon, first described by Richter (1928) . Lortholary, Boiron, Ripault, Levy, Manus, and Bernard (1964) presented four cases, reviewed the previous reports, and suggested the term 'Richter's syndrome' for this association. Three further cases were reported by Givler (1968) (Penn and Starzl, 1972) . Similarly, Fialkow, Klein, Gartler, and Clifford (1970) and Fialkow, Klein, and Clifford (1972) Following the demonstration of the two pathways of normal lymphoid differentiation, the thymic-(T cell) and bursal-(B cell) dependent systems, it has been suggested that lymphoid malignancies may be classified (or subclassified) according to which system has given rise to the neoplastic cells (Cooper, Peterson, Gabriesen, and Good, 1966; Miller, 1967) . The immunological abnormalities found in patients with Hodgkin's disease (Aisenberg, 1964; Aisenberg, 1966; Chase, 1966) point to a defect in the thymus system, and Hodgkin's disease may be a tumour of thymic-dependent cells (Cooper et al, 1966) . However, the origin of Sternberg-Reed cells remains unsettled. Rappaport (1964 Rappaport ( , 1966 ) considers them to be altered (neoplastic) histiocytes. Braunstein, Frieman, and Gall (1958) and Braunstein, Frieman, Thomas, and Gall (1962a and b) (Wright, 1964; Dorfman, 1961 Dorfman, , 1964 Dorfman, , 1972 . Tumours arising from the B cell system may feature inicreased immunoglobulin production with a raised level of plasma globulin, or the neoplastic cells may display functional dedifferentiation and hypoglobulinaemia may develop as systematization occurs and tumour cells progressively replace the normal. This sequence is common in patients with chronic lymphocytic leukaemia (Fairley and Scott, 1961) . In plasmacytomas, biochemical dedifferentiation often parallels the degree of malignancy (Hobbs, 1971) . Aisenberg and Bloch (1972) Wilson and Nossal (1971) and Wybran, Chantler, and Fudenberg (1973) . Smith, Barker, Clein, and Collins (1973) 
